• Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Health Care Supplies

Staar Surgical Co

+ Add to Watchlist


12.535 EUR 0.425 3.51%

As of 02:08:29 ET on 04/17/2014.

Snapshot for Staar Surgical Co (SR3)

Open: 12.435 Day's Range: 12.433 - 12.535 Volume: 0
Previous Close: 12.110 52wk Range: 4.676 - 13.724 1-Yr Rtn: +168.07%

Stock Chart for SR3

No chart data available.
  • SR3:GR 12.433
  • 1D
  • 1M
  • 1Y
Interactive SR3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SR3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 82.4743
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.2100
Est. PEG Ratio 3.2990
Market Cap (M EUR) 475.92
Shares Outstanding (M) 37.97
30 Day Average Volume 17
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SR3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SR3

STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.

Barry Gale CaldwellPresident/CEODonald J Todd "Don" President:Asia Pacific
Hans-Martin BlickensdoerferPresident:EuropeDeborah AndrewsVP/Chief Acctg Officer
More Company Profile & Key Executives for SR3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil